Mechanisms of enhanced production of PGI2 in cultured rat vascular smooth muscle cells enriched with eicosapentaenoic acid
- 1 June 1997
- journal article
- Published by Elsevier in Atherosclerosis
- Vol. 131 (2) , 219-228
- https://doi.org/10.1016/s0021-9150(97)00048-8
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Eicosapentaenoic acid and adult diseases in Japan: epidemiological and clinical aspectsJournal of Internal Medicine, 1989
- Eicosapentaenoic acid utilization by bovine aortic endothelial cells: effects on prostacyclin productionBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1986
- Effects of orally administered ethyl ester of eicosapentaenoic acid (EPA; C20:5, ω-3) on PGI2-like substance production by rat aortaProstaglandins, 1982
- Fish oil feeding lowers thromboxane- and prostacyclin production by rat platelets and aorta and does not result in the formation of prostaglandin I3Prostaglandins, 1981
- Epidemiological Studies in the Upernavik District, GreenlandActa Medica Scandinavica, 1980
- Inhibition of prostaglandin biosynthesis by eicosapentaenoic acidProstaglandins and Medicine, 1979
- Effects of all CIS-5, 8,11,14,17 eicosapentaenoic acid and PGH3 on platelet aggregationProstaglandins, 1979
- Triene prostaglandins: Prostacyclin and thromboxane biosynthesis and unique biological propertiesProceedings of the National Academy of Sciences, 1979
- Evidence for the mechanism by which eicosapentaenoic acid inhibits human platelet aggregation and secretion - implications for the prevention of vascular diseaseThrombosis Research, 1979
- EICOSAPENTAENOIC ACID AND PREVENTION OF THROMBOSIS AND ATHEROSCLEROSIS?Published by Elsevier ,1978